6 Results for "

anti-CD30

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "anti-CD30" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P99107A
CAS No.: 914088-09-8
Research Areas:  

Cancer

Brentuximab vedotin (solution) (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE). The antibody portion is Brentuximab (HY-P99151), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Brentuximab vedotin (solution) inhibits CD30-positive cells with an IC50 of 2.5 ng/mL. Brentuximab vedotin (solution) can be used for the research of relapsed and refractory Hodgkin lymphoma .
loading...
    loading...
Cat. No.: HY-P99669
CAS No.: 640735-09-7
Synonyms: MDX-060

Target:  

TNF Receptor

Research Areas:  

Cancer

Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) .
loading...
    loading...
Cat. No.: HY-P991553

Target:  

TNF Receptor Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

HeFi-1 is a mouse anti-CD30 IgG1 monoclonal antibody. HeFi-1 recognizes the ligand-binding site on CD30. HeFi-1 can inhibit the growth of tumor cells with high expression of CD30. HeFi-1 can induce eosinophil apoptosis. HeFi-1 can be used for researches on cancer or inflammation conditions such as anaplastic large-cell lymphoma (ALCL) and asthma .
loading...
    loading...
Cat. No.: HY-P991909

Target:  

TNF Receptor

Research Areas:  

Others

Anti-CD30L Antibody is an antibody against human CD30L. Recommend Isotype Controls:?Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-180412
CAS No.: 226072-63-5
Synonyms: BB-3644
Target:  

MMP

Research Areas:  

Cancer

Solimastat (BB-3644) is a potent metalloproteinase (MMP) inhibitor that blocks constitutive and antibody-stimulated CD30 shedding from cell surfaces with an IC50 of 180 nM. Solimastat enhances persistence of anti-CD30 antibody Ki-3 on cells and favors its internalization. Solimastat enhances cytotoxic activity of Ki-3.dgA towards CD30 + L540 cells. Solimastat can be used for the research of CD30 + malignancies .
loading...
    loading...
Cat. No.: HY-187336
CAS No.: 3087291-80-0
Target:  

NAMPT

Research Areas:  

Cancer

Nampt-IN-22 is a nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-22 blocks the NAD + salvage synthesis pathway by inhibiting nicotinamide phosphoribosyltransferase (NAMPT). Its tertiary alcohol forms hydrogen bonds with His191 of NAMPT and enhances lysosomal stability via intramolecular hydrogen bonds. As an ADC payload, Nampt-IN-22 exhibits low nanomolar cytotoxicity against tumor cells after conjugation to an anti-CD30 antibody, prolongs survival in a disseminated L540 Hodgkin lymphoma mouse model, and suppresses subcutaneous tumor growth. Nampt-IN-22 can be used in studies related to Hodgkin lymphoma .
loading...
    loading...